Overview Of COVID-19: Global Clinical Trial Landscape

Dive into a comprehensive overview of COVID-19, and learn about the severe, infectious disease caused by the SARS-CoV-2 virus that led to a global pandemic. In this article you will learn about the staggering statistics and the range of symptoms, from mild to severe, highlighting the disease's varied impact. Treatment approaches differ based on severity, with antivirals for mild cases and more intensive therapies for critical patients. The importance of vaccination in reducing transmission and severity is emphasized, alongside the challenges posed by emerging variants like Alpha, Delta, and Omicron. The text also discusses the extensive global research efforts, including 5,000 clinical trials, primarily concentrated in the Asia-Pacific region. Furthermore, advancements in vaccine and therapeutic strategies, spearheaded by companies like Pfizer and Moderna, are crucial for improving outcomes and preparing for potential future pandemics.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.